Beurs.nl
Uitgebreid zoeken
monitor iconMarkt Monitor
  • AEX +18,89 838,45 +2,30%
  • DE40 0,00 20.374,10 0,00%
  • US500^ +71,56 5.429,82 +1,34%
  • US30^ +358,80 40.572,80 +0,89%
  • EUR/USD +0,01 1,1387 +0,59%
  • WTI +0,84 62,32 +1,37%
  • Gold spot -21,74 3.215,73 -0,67%

Amerikaanse aandelen Terug naar discussie overzicht

Intertainment Media Inc: INT.V

50 Posts
Pagina: «« 1 2 3 | Laatste | Omlaag ↓
  7. [verwijderd] 9 november 2011 11:23

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Consolideert al een maandje rond de .53, terwijl de beurzen de afgelopen maand wel up zijn gegaan...Is meestal niet zo n goed teken toch? Of wordt er op korte termijn iets verwacht?
  8. [verwijderd] 9 november 2011 15:38

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    @Doniss

    ...On October 14, 2011, Ortsbo's parent, Intertainment Media Inc. published its Corporate Update for the fiscal year ended June 30, 2011 and commented that in the past year, management and the board have rejected 2 independent offers for Ortsbo to effectively divest primary ownership of Ortsbo. The US investment market for social media acquisitions and public offerings continues to grow. The investment markets have seen highly successful IPO debuts of several social media companies and the much anticipated potential IPOs for Zynga and Facebook are continual newsworthy items.

    Given the performance of Ortsbo, management and the board feel that the current overall corporate and shareholder value does not reflect the enterprise value of the sum of the divisions, especially Ortsbo. The Company is currently reviewing strategy and opportunities where Intertainment will potentially unlock maximum valuation for Ortsbo while retaining significant ownership and future benefits from the continual growth and performance in the program while potentially creating a special dividend for shareholders, rewarding them for the continual support of the Company. The Company will report on these efforts in due course...

    www.marketwire.com/press-release/inte...
50 Posts
Pagina: «« 1 2 3 | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beurs.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.166
AB InBev 2 5.545
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.511
ABO-Group 1 25
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.931
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 193
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.893
Aedifica 3 927
Aegon 3.258 323.214
AFC Ajax 538 7.093
Affimed NV 2 6.306
ageas 5.844 109.911
Agfa-Gevaert 14 2.075
Ahold 3.538 74.363
Air France - KLM 1.025 35.335
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.075
Alfen 16 25.508
Allfunds Group 4 1.525
Almunda Professionals (vh Novisource) 651 4.253
Alpha Pro Tech 1 17
Alphabet Inc. 1 427
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 244.276
AMG 972 134.770
AMS 3 73
Amsterdam Commodities 305 6.757
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 501
Antonov 22.632 153.605
Aperam 92 15.110
Apollo Alternative Assets 1 17
Apple 5 387
Arcadis 252 8.808
Arcelor Mittal 2.035 321.103
Archos 1 1
Arcona Property Fund 1 287
arGEN-X 17 10.382
Aroundtown SA 1 221
Arrowhead Research 5 9.759
Ascencio 1 30
ASIT biotech 2 697
ASMI 4.108 39.702
ASML 1.767 112.403
ASR Nederland 21 4.522
ATAI Life Sciences 1 7
Atenor Group 1 523
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 14.358
Axsome Therapeutics 1 177
Azelis Group 1 69
Azerion 7 3.463